Results 21 to 30 of about 11,110,115 (247)

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry [PDF]

, 2012
<p>Aims Men and women differ in terms of presentation and management in coronary artery disease (CAD). Whether these differences translate into different clinical outcomes in stable CAD is unclear.
Jean Claude Tardif, Stefan Ka, Tendera, M., Ford, I, Fox, KM, Ferrari, R., Abergel, H., Abergel, H, Ian Ford, Ford, I., Michal Tendera, Gabriel Steg, Fox, K.M., Tendera, M, Kim M. Fox, FERRARI, Roberto, Steg, PG, Greenlaw, N, Kaeaeb, S, Greenlaw, N., Tardif, J.-C., Kaab, S., Nicola Greenlaw, Tardif, J-C, Steg, P.G., Ferrari, R, on behalf of the CLARIFY Registry Investigators, He ́ le`ne Abergel   +27 more
core   +1 more source

Frequency of thrombocytopenia in severe COVID-19

Pakistan Journal of Pharmaceutical Sciences, 2022
To aim of the study was to determine the frequency of thrombocytopenia and its effect on clinical outcomes in South Asian patients admitted with severe COVID-19.
Mehak Hanif, Kamran Khan Sumalani, Zarkesh Shaikh, Vishal Mandhan, Shahbaz Haider   +4 more
doaj   +1 more source

Outcomes in Trials for Management of Caries Lesions (OuTMaC):protocol [PDF]

, 2015
BackgroundClinical trials on caries lesion management use an abundance of outcomes, hampering comparison or combination of different study results and their efficient translation into clinical practice.
Lamont, T., Lamont, Thomas; id_orcid, Thomas Lamont, Schwendicke, F., Schwendicke, Falk, Innes, Nicola; id_orcid, Falk Schwendicke, Nicola Innes, Innes, N.   +8 more
core   +2 more sources

Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs [PDF]

, 2017
This review describes the pharmacokinetic properties of the systemically administered antileishmanial drugs pentavalent antimony, paromomycin, pentamidine, miltefosine and amphotericin B (AMB), including their absorption, distribution, metabolism and ...
Schellens, Jan H M, Dorlo, Thomas P. C.,, Kip, Anke E., Thomas P. C. Dorlo, Kip, Anke E, Schellens, Jan H. M., Beijnen, Jos H., Beijnen, Jos H.,, Schellens, Jan H. M.,, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology, Dorlo, Thomas P. C., Dorlo, Thomas P C, Anke E. Kip, Kip, Anke E.,, Jos H. Beijnen, Beijnen, Jos H, Jan H. M. Schellens   +17 more
core   +1 more source

Burden of illness of trigeminal neuralgia among patients managed in a specialist center in England

The Journal of Headache and Pain, 2020
Background Trigeminal neuralgia (TN) causes severe episodic, unilateral facial pain and is initially treated with antiepileptic medications. For patients not responding or intolerant to medications, surgery is an option.
Lasair O’Callaghan, Lysbeth Floden, Lisa Vinikoor-Imler, Tara Symonds, Kathryn Giblin, Chris Hartford, Joanna M. Zakrzewska   +6 more
doaj   +1 more source

Developing Angelman syndrome-specific clinician-reported and caregiver-reported measures to support holistic, patient-centered drug development

Orphanet Journal of Rare Diseases, 2023
Background Angelman syndrome (AS) is a rare, heterogenous neurogenetic condition, which significantly impacts the lives of people with AS and their families. Valid and reliable measures reporting key symptoms and functional impairments of AS are required
Siobhan Connor-Ahmad, Jorrit Tjeertes, Michael Chladek, Louise Newton, Tara Symonds, Susanne Clinch, Brenda Vincenzi, Fiona McDougall   +7 more
doaj   +1 more source

Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: qualitative interview findings

Journal of Patient-Reported Outcomes, 2022
Background There is interest in participants using their own smartphones or tablets (“bring your own device”; BYOD) to complete patient-reported outcome (PRO) measures in clinical studies.
Louise Newton, Oliver Knight-West, Sonya Eremenco, Stacie Hudgens, Mabel Crescioni, Tara Symonds, David S. Reasner, Bill Byrom, Paul O’Donohoe, Susan Vallow, the Patient-Reported Outcome (PRO) Consortium, Electronic Clinical Outcome Assessment (eCOA) Consortium   +11 more
doaj   +1 more source

Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference

Medical Cannabis and Cannabinoids, 2022
The Consortium for Medical Marijuana Clinical Outcomes Research, a multi-university collaboration established by the state of Florida in the USA, hosted its second annual Cannabis Clinical Outcomes Research Conference (CCORC) in May 2022.
Nicole E. Smolinski, Ruba Sajdeya, Robert Cook, Yan Wang, Almut G. Winterstein, Amie Goodin   +5 more
doaj   +1 more source

Patient‐Reported Outcome Measures for Severe Recurrent Bilateral Nasal Polyps: Psychometric Evaluation and Content Validity

OTO Open, 2023
Objective To date, no patient‐reported outcome measures have been specifically developed to assess pharmacological treatment effect in participants with severe chronic rhinosinusitis (CRS) with recurrent bilateral nasal polyps (NP).
Adam Gater, Chloe Tolley, Rebecca Williams‐Hall, Claire Trennery, Helena Bradley, Mirko V. Sikirica, Linda Nelsen, Ana R. Sousa, Daniel J. Bratton, Robert Chan, Robyn vonMaltzahn   +10 more
doaj   +1 more source

The Glioma Outcomes Project: a resource for measuring and improving glioma outcomes

, 2011
The author describes the Glioma Outcomes (GO) Project which conducts outcomes research and develops educational programs to benefit patients who undergo surgery for glioma.
The Glioma Outcomes Project Advisory Board, Anderson, Frederick A. Jr.   +1 more
core   +1 more source